[Vulvar lesions caused by Papillomavirus (HPV): effectiveness of thymopentin (Syntomoduline). First results and experiences].
The study included two different sized groups of patients suffering from various degrees of valvular microcondylomatosis. A group of 40 patients was treated using combined therapy while a second group of 20 patients received immunomodulating therapy alone with Sintomodulin. In particular, possible changes in the T-cell line of the immune system and correlations between the viral lesion and variations in serum levels of lymphocyte subpopulations were assessed. Results were analysed up to one year after the end of therapy.
Di Stefano
L
L
Cattedra di Patologia Ostetrica e Ginecologica, Università degli Studi de L'Aquila.
Facchini
D
D
De Paulis
A L
AL
Cappa
F
F
Moscarini
M
M
D000293:Adolescent; D000328:Adult; D003218:Condylomata Acuminata / Q000188:drug therapy / Q000382:microbiology*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D027383:Papillomaviridae / Q000187:drug effects; D016305:Thymopentin / Q000627:therapeutic use*; D014846:Vulvar Neoplasms / Q000188:drug therapy / Q000382:microbiology*
D016305:Thymopentin
Lesioni vulvari da papillomavirus (HPV): efficacia della timopentina (Sintomodulina). Nostri primi risultati ed esperienze.